Industry-chain Research Brief

CNR Automobile Inspection Center (Kunming) Co., Ltd.: Biomedicine Little Giant Industry Chain Brief

Yunnan · Biomedicine · 2026-06-12

English company profile Full Chinese report All report summaries

English Summary

CNR Automobile Inspection Center (Kunming) Co., Ltd. is a China Little Giant company report summary for overseas readers. The company is associated with Yunnan. The report is indexed under Biomedicine. The Chinese report was published on 2026-06-12. The summary covers company profile, product direction, industry-chain role, technology, patent/R&D signals, scale indicators and policy-material checkpoints.

Report Snapshot

CompanyCNR Automobile Inspection Center (Kunming) Co., Ltd.
RegionYunnan
IndustryBiomedicine
Published2026-06-12
Chinese reportOpen
CompanyCNR Automobile Inspection Center (Kunming) Co., Ltd.
Region / IndustryYunnan · Biomedicine
Recognition2023 5th batch
Patent signalPatent count not available

Company and Recognition Snapshot

CNR Automobile Inspection Center (Kunming) Co., Ltd. is indexed as a national-level Little Giant enterprise in Yunnan. The English profile places the company under Biomedicine and records 2023 5th batch as the available recognition context.

Recognition batch2023 5th batch
RegionYunnan
IndustryBiomedicine
Registered capitalRMB 300.00 million
Employee signal53 employees
Listed statusNot listed
Patent signalPatent count not available
R&D signalR&D investment detail not published in the English dataset

Business and Industry-chain Position

Chinese public records indicate medical-device or biomedicine activity. The recorded industry-chain position is Automotive and transport equipment / Recorded position. This places the company in a policy-relevant segment for peer comparison by region, industry and batch.

Technology, Patent and R&D Signals

The public profile records Patent count not available. The R&D signal is: R&D investment detail not published in the English dataset. Patent and R&D information should be read with product direction, customer evidence and chain position rather than as isolated threshold items.

Policy-material Review Points

  • Verify whether the company's main business, niche market and product evidence all point to Biomedicine.
  • Check that patent, R&D, employee and financial fields support the same core product direction.
  • Compare the company with peers in the same province, industry and recognition batch before using the profile for supplier screening or policy research.
  • Use the linked Chinese source report for original-language evidence and source links.

Original Report and Profile

For the underlying database record, open the English company profile. For full-length analysis, original-language wording and public evidence links, open the Chinese source report.

Related Search Paths